Answers are grounded in this paper and cite their sources.
T he objective of this subcommittee was to summarize the evidence in clinical trials on meibomian gland dysfunction (MGD) and to use this information to make recommendations for best-practice clinical trial design for this condition.
No takes yet. Share an insight, caveat, or question.
Asbell et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: